Biomarker testing is a key part of personalized cancer care. It identifies specific molecular changes in a tumour to help guide treatment decisions and improve patient outcomes, ensuring patients get the right treatment at the right time.

Despite its importance, access to biomarker testing in Canada remains inconsistent. Barriers such as uneven availability, delays in testing, limited awareness among patients and healthcare providers, lack of coordination across care teams, and funding constraints prevent many patients from benefiting from this essential tool. These challenges are often greater for people living in rural and remote communities.